Abstract The US Food and Drug Administration (FDA) Adverse Event Reporting System
(FAERS, formerly AERS) is a database that contains information on adverse event and …

Case–non-case studies are among the methods used to assess drug safety by analyzing the
disproportionality of adverse drug reaction reports in pharmacovigilance databases. First …

Drug use in medicine is based on a balance between expected benefits (already
investigated before marketing authorization) and possible risks (ie, adverse effects), which …

This survey analyzes two national pharmacovigilance databases in order to determine the
major adverse reactions observed with the use of cholinesterase inhibitors in dementia. We …

Background Most pharmacovigilance departments maintain a system to identify adverse
drug reactions (ADRs) through analysis of spontaneous reports. The signal detection …

Objective This study aimed to identify the most common and top drugs associated with the
risk of torsades de pointes (TdP) based on the United States Food and Drug Administration …

Background A series of signal detection methods have been developed to detect adverse
drug reaction (ADR) signals in spontaneous reporting system. However, different signal …

Study Objective Acute kidney injury (AKI) is a common condition associated with both short‐
term and long‐term consequences including dialysis, chronic kidney disease, and mortality …

Background: Tildrakizumab, the IL-23 inhibitor, is used to treat plaque psoriasis and
psoriatic arthritis. Many studies have reported adverse drug reactions (ADRs) associated …

Introduction: Linezolid is an oxazolidinone antibiotic that is active against drug-resistant
Gram-positive bacteria and multidrug-resistant Mycobacterium tuberculosis. Real-world …